SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

KYNB

KYNTRA BIO, INC.
NASDAQHealth Care

Latest close: 4.85 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 31, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,1149 flagged findings
Reported transactions (Form 4)80since Feb 21, 2023 · and 7 other holdings
Corporate events (8-K)30since Jun 8, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Identity

Formerly traded as FGEN.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Oct 6, 2026).

Deadline: Sep 29, 2026 · passed

  • stockholders' equity · Nasdaq, rule 5450(b)(3)(A) · notice of Apr 2, 2026 · delisting determination · deadline Sep 29, 2026 (derived from the rule, not confirmed in the text) · first period expired; a second 180-day period may exist that is not on record
  • market value of listed securities · Nasdaq, rule 5450(b)(3)(A) · notice of Apr 2, 2026 · delisting determination · deadline Sep 29, 2026 (derived from the rule, not confirmed in the text) · first period expired; a second 180-day period may exist that is not on record

Open the 8-K at the SEC

Reverse splits in 5 years

1 reverse split in 5 years (1:25 on Jun 17, 2025) · 1:25 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,114)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 6, 26Form 4 ↗Insider transaction
  • Oct 6, 26Form 3 ↗Insider transaction
  • Oct 6, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Oct 1, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 31, 268-K ↗Current report · Entered a material agreement
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 9.9% · event on Jun 30, 26 · amendment
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 13, 268-K ↗Current report · Results
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Jun 16, 268-K ↗Current report · Shareholder vote results
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Jun 9, 268-K ↗Current report · Other events
  • May 19, 26Form 4/A ↗Insider transaction · amendment
  • May 18, 26Form 4 ↗Insider transaction
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 9.9% · event on Mar 31, 26 · amendment
  • May 12, 2610-Q ↗Quarterly report
  • May 11, 268-K ↗Current report · Results
  • Apr 27, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 27, 26DEF 14A ↗Shareholder meeting and votes

1,114 filings on record, the oldest from Nov 13, 14.

Listing the 25 most recent filings of the 1,114 on record.

8-Ks, explained

Stress7Structure22Governance31
  • Oct 6, 26StressListing notice (8-K 3.01)the filing reports the decision to delist8-K 3.01 ↗
  • Oct 1, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 31, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Apr 9, 26StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Sep 5, 25StructureCompleted an acquisition or disposal+1 more in the same filing8-K 2.01 ↗
  • Aug 14, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 14, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jun 13, 25StructureA material agreement was terminated8-K 1.02 ↗
  • Jun 9, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Mar 28, 25StructureEntered a material agreement8-K 1.01 ↗
  • Mar 17, 25StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Feb 24, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

14 older filings not shown · The record reaches back to Aug 12, 15.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 7 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Armistice Capital, LLC9.9%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 6 earlier filings
  • PRIMECAP MANAGEMENT CO/CA/4.6%Dec 31, 24SCHEDULE 13G/A ↗
  • The Vanguard Group4.4%Jun 30, 25SCHEDULE 13G/A ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • May 14, 26Buy$20KThane WettigCEO↗
  • Nov 17, 25Buy$25KThane WettigCEO↗
  • Nov 13, 25Buy$9KThane WettigCEO↗
  • Jun 30, 25Buy$119KJames A Schoeneck↗
  • Mar 24, 25Buy$51KThane WettigCEO↗
  • Mar 21, 25Buy$17KJames A Schoeneck↗
  • Mar 20, 25Buy$88KJames A Schoeneck↗
  • Jun 12, 24Buy$26KDeyaa AdibChief Medical Officer↗
Stock compensation, tax and giftsshow the 32 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 6, 26Tax$2KThane WettigCEO↗
  • Sep 6, 26Tax$188David DeLuciaChief Financial Officer↗
  • Jun 6, 26Tax$1KThane WettigCEO↗
  • Jun 6, 26Tax$349David DeLuciaChief Financial Officer↗
  • Mar 6, 26Tax$2KThane WettigCEO↗
  • Mar 6, 26Tax$410David DeLuciaChief Financial Officer↗
  • Dec 6, 25Tax$2KThane WettigCEO↗
  • Dec 6, 25Tax$438David DeLuciaChief Financial Officer↗
  • Sep 6, 25Tax$3KThane WettigCEO↗
  • Sep 6, 25Tax$641David DeLuciaChief Financial Officer↗
  • Jun 6, 25Tax$2KThane WettigCEO↗
  • Jun 6, 25Tax$399David DeLuciaChief Financial Officer↗
  • Mar 6, 25Tax$907David DeLuciaChief Financial Officer↗
  • Mar 6, 25Tax$3KChristine ChungSVP, CHINA OPERATIONS↗
  • Mar 6, 25Compensationamount n/aChristine ChungSVP, CHINA OPERATIONS↗
  • Mar 6, 25Tax$165Christine ChungSVP, CHINA OPERATIONS↗
  • Mar 6, 25Tax$9KThane WettigCEO↗
  • Mar 6, 25Compensationamount n/aThane WettigCEO↗
  • Mar 6, 25Tax$143Thane WettigCEO↗
  • Dec 7, 24Tax$365Juan GrahamCHIEF FINANCIAL OFFICER↗
  • Dec 6, 24Tax$955Christine ChungSVP, CHINA OPERATIONS↗
  • Dec 6, 24Tax$808Thane WettigCEO↗
  • Dec 6, 24Tax$495Juan GrahamCHIEF FINANCIAL OFFICER↗
  • Sep 7, 24Tax$415Juan GrahamCHIEF FINANCIAL OFFICER↗
  • Sep 6, 24Tax$7KChristine ChungSVP, CHINA OPERATIONS↗
  • Sep 6, 24Tax$922Thane WettigCEO↗
  • Sep 6, 24Tax$6KJuan GrahamCHIEF FINANCIAL OFFICER↗
  • Aug 1, 24Tax$10KThane WettigCEO↗
  • Jun 22, 24Tax$884Thane WettigCEO↗
  • Jun 7, 24Tax$1KJuan GrahamCHIEF FINANCIAL OFFICER↗
  • Jun 6, 24Tax$3KThane WettigCEO↗
  • Jun 6, 24Tax$23KChristine ChungSVP, CHINA OPERATIONS↗

The full record holds 158 transactions and goes back to May 25, 22.

Its sector and its market

KYNTRA BIO, INC. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From KYNTRA BIO, INC., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow KYNTRA BIO, INC. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,114 documents on file, from Nov 13, 2014 to Oct 6, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.